Reprogramming aging and progeria

Current Opinion in Cell Biology

Volumn 24, Issue 6, 2012, Pages 757-764

  Freije, José MP ^a   López Otín, Carlos ^a  

^a DEPARTAMENTO DE BIOQUÍMICA Y BIOLOGÍA MOLECULAR   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

MAMMALIAN TARGET OF RAPAMYCIN; SOMATOMEDIN C;

AGING; DEGENERATION; EPIGENETICS; HUMAN; ONSET AGE; PRIORITY JOURNAL; PROGERIA; REVIEW; STEM CELL; TISSUE REPAIR;

AGING; ANIMALS; CELL AGING; EPIGENESIS, GENETIC; HUMANS; LONGEVITY; NUCLEAR REPROGRAMMING; PROGERIA; REJUVENATION; STEM CELLS;

EID: 84871935697     PISSN: 09550674     EISSN: 18790410     Source Type: Journal    
DOI: 10.1016/j.ceb.2012.08.009     Document Type: Review

References (88)

1. Martin G.M. The biology of aging: 1985-2010 and beyond. FASEB J 2011, 25:3756-3762.
2. Kirkwood T.B. Understanding the odd science of aging. Cell 2005, 120:437-447.
3. Hayflick L. Biological aging is no longer an unsolved problem. Ann N Y Acad Sci 2007, 1100:1-13.
4. Kirkwood T.B., Melov S. On the programmed/non-programmed nature of ageing within the life history. Curr Biol 2011, 21:R701-R707.
5. Skulachev V.P. Aging as a particular case of phenoptosis, the programmed death of an organism (a response to Kirkwood and Melov " On the programmed/non-programmed nature of ageing within the life history" ). Aging (Albany NY) 2011, 3:1120-1123.
6. Bredesen D.E. The non-existent aging program: how does it work?. Aging Cell 2004, 3:255-259.
7. Guarente L., Kenyon C. Genetic pathways that regulate ageing in model organisms. Nature 2000, 408:255-262.
8. Kenyon C.J. The genetics of ageing. Nature 2010, 464:504-512.
9. Levine A.J., Oren M. The first 30 years of p53: growing ever more complex. Nat Rev Cancer 2009, 9:749-758.
10. Johnson T.E., Wood W.B. Genetic analysis of life-span in Caenorhabditis elegans. Proc Natl Acad Sci U S A 1982, 79:6603-6607.
11. Kimura K.D., Tissenbaum H.A., Liu Y., Ruvkun G. daf-2, an insulin receptor-like gene that regulates longevity and diapause in Caenorhabditis elegans. Science 1997, 277:942-946.
12. Kenyon C., Chang J., Gensch E., Rudner A., Tabtiang R. A C. elegans mutant that lives twice as long as wild type. Nature 1993, 366:461-464.
13. Russell S.J., Kahn C.R. Endocrine regulation of ageing. Nat Rev Mol Cell Biol 2007, 8:681-691.
14. Laplante M., Sabatini D.M. mTOR signaling in growth control and disease. Cell 2012, 149:274-293.
15. Vellai T., Takacs-Vellai K., Zhang Y., Kovacs A.L., Orosz L., Muller F. Genetics: influence of TOR kinase on lifespan in C. elegans. Nature 2003, 426:620.
16. Harrison D.E., Strong R., Sharp Z.D., Nelson J.F., Astle C.M., Flurkey K., Nadon N.L., Wilkinson J.E., Frenkel K., Carter C.S., et al. Rapamycin fed late in life extends lifespan in genetically heterogeneous mice. Nature 2009, 460:392-395.
17. Miller R.A., Harrison D.E., Astle C.M., Baur J.A., Boyd A.R., de Cabo R., Fernandez E., Flurkey K., Javors M.A., Nelson J.F., et al. Rapamycin, but not resveratrol or simvastatin, extends life span of genetically heterogeneous mice. J Gerontol A Biol Sci Med Sci 2011, 66:191-201.
18. Selman C., Tullet J.M., Wieser D., Irvine E., Lingard S.J., Choudhury A.I., Claret M., Al-Qassab H., Carmignac D., Ramadani F., et al. Ribosomal protein S6 kinase 1 signaling regulates mammalian life span. Science 2009, 326:140-144.
19. Rogers A.N., Chen D., McColl G., Czerwieniec G., Felkey K., Gibson B.W., Hubbard A., Melov S., Lithgow G.J., Kapahi P. Life span extension via eIF4G inhibition is mediated by posttranscriptional remodeling of stress response gene expression in C. elegans. Cell Metab 2011, 14:55-66.
20. Toth M.L., Sigmond T., Borsos E., Barna J., Erdelyi P., Takacs-Vellai K., Orosz L., Kovacs A.L., Csikos G., Sass M., et al. Longevity pathways converge on autophagy genes to regulate life span in Caenorhabditis elegans. Autophagy 2008, 4:330-338.
21. Hansen M., Chandra A., Mitic L.L., Onken B., Driscoll M., Kenyon C. A role for autophagy in the extension of lifespan by dietary restriction in C. elegans. PLoS Genet 2008, 4:e24.
22. Rubinsztein D.C., Marino G., Kroemer G. Autophagy and aging. Cell 2011, 146:682-695.
23. Anisimov V.N., Berstein L.M., Egormin P.A., Piskunova T.S., Popovich I.G., Zabezhinski M.A., Tyndyk M.L., Yurova M.V., Kovalenko I.G., Poroshina T.E., et al. Metformin slows down aging and extends life span of female SHR mice. Cell Cycle 2008, 7:2769-2773.
24. Apfeld J., O'Connor G., McDonagh T., DiStefano P.S., Curtis R. The AMP-activated protein kinase AAK-2 links energy levels and insulin-like signals to lifespan in C. elegans. Genes Dev 2004, 18:3004-3009.
25. Berstein L.M. Metformin in obesity, cancer and aging: addressing controversies. Aging (Albany NY) 2012, 4:320-329.
26. Chalkiadaki A., Guarente L. Sirtuins mediate mammalian metabolic responses to nutrient availability. Nat Rev Endocrinol 2012, 8:287-296.
27. Houtkooper R.H., Pirinen E., Auwerx J. Sirtuins as regulators of metabolism and healthspan. Nat Rev Mol Cell Biol 2012, 13:225-238.
28. Burnett C., Valentini S., Cabreiro F., Goss M., Somogyvari M., Piper M.D., Hoddinott M., Sutphin G.L., Leko V., McElwee J.J., et al. Absence of effects of Sir2 overexpression on lifespan in C. elegans and Drosophila. Nature 2011, 477:482-485.
29. Herranz D., Munoz-Martin M., Canamero M., Mulero F., Martinez-Pastor B., Fernandez-Capetillo O., Serrano M. Sirt1 improves healthy ageing and protects from metabolic syndrome-associated cancer. Nat Commun 2010, 1:3.
30. Kanfi Y., Naiman S., Amir G., Peshti V., Zinman G., Nahum L., Bar-Joseph Z., Cohen H.Y. The sirtuin SIRT6 regulates lifespan in male mice. Nature 2012, 483:218-221.
31. Nakagawa T., Guarente L. Sirtuins at a glance. J Cell Sci 2011, 124:833-838.
32. Agarwal B., Baur J.A. Resveratrol and life extension. Ann N Y Acad Sci 2011, 1215:138-143.
33. Tilstra J.S., Clauson C.L., Niedernhofer L.J., Robbins P.D. NF-kappaB in aging and disease. Aging Dis 2011, 2:449-465.
34. Adler A.S., Sinha S., Kawahara T.L., Zhang J.Y., Segal E., Chang H.Y. Motif module map reveals enforcement of aging by continual NF-kappaB activity. Genes Dev 2007, 21:3244-3257.
35. Kawahara T.L., Michishita E., Adler A.S., Damian M., Berber E., Lin M., McCord R.A., Ongaigui K.C., Boxer L.D., Chang H.Y., et al. SIRT6 links histone H3 lysine 9 deacetylation to NF-kappaB-dependent gene expression and organismal life span. Cell 2009, 136:62-74.
36. Blasco M.A. Telomere length, stem cells and aging. Nat Chem Biol 2007, 3:640-649.
37. Fumagalli M., Rossiello F., Clerici M., Barozzi S., Cittaro D., Kaplunov J.M., Bucci G., Dobreva M., Matti V., Beausejour C.M., et al. Telomeric DNA damage is irreparable and causes persistent DNA-damage-response activation. Nat Cell Biol 2012, 14:355-365.
38. Hewitt G., Jurk D., Marques F.D., Correia-Melo C., Hardy T., Gackowska A., Anderson R., Taschuk M., Mann J., Passos J.F. Telomeres are favoured targets of a persistent DNA damage response in ageing and stress-induced senescence. Nat Commun 2012, 3:708.
39. Ungar L., Harari Y., Toren A., Kupiec M. Tor complex 1 controls telomere length by affecting the level of Ku. Curr Biol 2011, 21:2115-2120.
40. Hoffmeyer K., Raggioli A., Rudloff S., Anton R., Hierholzer A., Del Valle I., Hein K., Vogt R., Kemler R. Wnt/beta-catenin signaling regulates telomerase in stem cells and cancer cells. Science 2012, 336:1549-1554.
41. Ramirez C.L., Cadinanos J., Varela I., Freije J.M., Lopez-Otin C. Human progeroid syndromes, aging and cancer: new genetic and epigenetic insights into old questions. Cell Mol Life Sci 2007, 64:155-170.
42. Burtner C.R., Kennedy B.K. Progeria syndromes and ageing: what is the connection?. Nat Rev Mol Cell Biol 2010, 11:567-578.
43. Yu C.E., Oshima J., Fu Y.H., Wijsman E.M., Hisama F., Alisch R., Matthews S., Nakura J., Miki T., Ouais S., et al. Positional cloning of the Werner's syndrome gene. Science 1996, 272:258-262.
44. Kudlow B.A., Kennedy B.K., Monnat R.J. Werner and Hutchinson-Gilford progeria syndromes: mechanistic basis of human progeroid diseases. Nat Rev Mol Cell Biol 2007, 8:394-404.
45. Osorio F.G., Navarro C.L., Cadinanos J., Lopez-Mejia I.C., Quiros P.M., Bartoli C., Rivera J., Tazi J., Guzman G., Varela I., et al. Splicing-directed therapy in a new mouse model of human accelerated aging. Sci Transl Med 2011, 3:106ra107.
46. Worman H.J. Nuclear lamins and laminopathies. J Pathol 2012, 226:316-325.
47. Osorio F.G., Ugalde A.P., Marino G., Puente X.S., Freije J.M., Lopez-Otin C. Cell autonomous and systemic factors in progeria development. Biochem Soc Trans 2011, 39:1710-1714.
48. Puente X.S., Quesada V., Osorio F.G., Cabanillas R., Cadinanos J., Fraile J.M., Ordonez G.R., Puente D.A., Gutierrez-Fernandez A., Fanjul-Fernandez M., et al. Exome sequencing and functional analysis identifies BANF1 mutation as the cause of a hereditary progeroid syndrome. Am J Hum Genet 2011, 88:650-656.
49. Cabanillas R., Cadinanos J., Villameytide J.A., Perez M., Longo J., Richard J.M., Alvarez R., Duran N.S., Illan R., Gonzalez D.J., et al. Nestor-Guillermo progeria syndrome: a novel premature aging condition with early onset and chronic development caused by BANF1 mutations. Am J Med Genet A 2011, 155A:2617-2625.
50. Robine J.M., Allard M. The oldest human. Science 1998, 279:1834-1835.
51. Schachter F., Faure-Delanef L., Guenot F., Rouger H., Froguel P., Lesueur-Ginot L., Cohen D. Genetic associations with human longevity at the APOE and ACE loci. Nat Genet 1994, 6:29-32.
52. Willcox B.J., Donlon T.A., He Q., Chen R., Grove J.S., Yano K., Masaki K.H., Willcox D.C., Rodriguez B., Curb J.D. FOXO3A genotype is strongly associated with human longevity. Proc Natl Acad Sci U S A 2008, 105:13987-13992.
53. Soerensen M., Dato S., Christensen K., McGue M., Stevnsner T., Bohr V.A., Christiansen L. Replication of an association of variation in the FOXO3A gene with human longevity using both case-control and longitudinal data. Aging Cell 2010, 9:1010-1017.
54. Conneely K.N., Capell B.C., Erdos M.R., Sebastiani P., Solovieff N., Swift A.J., Baldwin C.T., Budagov T., Barzilai N., Atzmon G., et al. Human longevity and common variations in the LMNA gene: a meta-analysis. Aging Cell 2012, 11:475-481.
55. Sebastiani P., Solovieff N., Dewan A.T., Walsh K.M., Puca A., Hartley S.W., Melista E., Andersen S., Dworkis D.A., Wilk J.B., et al. Genetic signatures of exceptional longevity in humans. PLoS One 2012, 7:e29848.
56. Sebastiani P., Riva A., Montano M., Pham P., Torkamani A., Scherba E., Benson G., Milton J.N., Baldwin C.T., Andersen S., et al. Whole genome sequences of a male and female supercentenarian, ages greater than 114 years. Front Genet 2011, 2:90.
57. Fraga M.F., Esteller M. Epigenetics and aging: the targets and the marks. Trends Genet 2007, 23:413-418.
58. Jin C., Li J., Green C.D., Yu X., Tang X., Han D., Xian B., Wang D., Huang X., Cao X., et al. Histone demethylase UTX-1 regulates C. elegans life span by targeting the insulin/IGF-1 signaling pathway. Cell Metab 2011, 14:161-172.
59. Osorio F.G., Varela I., Lara E., Puente X.S., Espada J., Santoro R., Freije J.M., Fraga M.F., Lopez-Otin C. Nuclear envelope alterations generate an aging-like epigenetic pattern in mice deficient in Zmpste24 metalloprotease. Aging Cell 2010, 9:947-957.
60. Olson M.O., Dundr M. The moving parts of the nucleolus. Histochem Cell Biol 2005, 123:203-216.
61. Swisshelm K., Disteche C.M., Thorvaldsen J., Nelson A., Salk D. Age-related increase in methylation of ribosomal genes and inactivation of chromosome-specific rRNA gene clusters in mouse. Mutat Res 1990, 237:131-146.
62. Krishnan V., Chow M.Z., Wang Z., Zhang L., Liu B., Liu X., Zhou Z. Histone H4 lysine 16 hypoacetylation is associated with defective DNA repair and premature senescence in Zmpste24-deficient mice. Proc Natl Acad Sci U S A 2011, 108:12325-12330.
63. Larson K., Yan S.J., Tsurumi A., Liu J., Zhou J., Gaur K., Guo D., Eickbush T.H., Li W.X. Heterochromatin formation promotes longevity and represses ribosomal RNA synthesis. PLoS Genet 2012, 8:e1002473.
64. Marino G., Ugalde A.P., Salvador-Montoliu N., Varela I., Quiros P.M., Cadinanos J., van der Pluijm I., Freije J.M., Lopez-Otin C. Premature aging in mice activates a systemic metabolic response involving autophagy induction. Hum Mol Genet 2008, 17:2196-2211.
65. Rossi D.J., Jamieson C.H., Weissman I.L. Stems cells and the pathways to aging and cancer. Cell 2008, 132:681-696.
66. Jones D.L., Rando T.A. Emerging models and paradigms for stem cell ageing. Nat Cell Biol 2011, 13:506-512.
67. Shen J., Tsai Y.T., Dimarco N.M., Long M.A., Sun X., Tang L. Transplantation of mesenchymal stem cells from young donors delays aging in mice. Sci Rep 2011, 1:67.
68. Cerletti M., Jang Y.C., Finley L.W., Haigis M.C., Wagers A.J. Short-term calorie restriction enhances skeletal muscle stem cell function. Cell Stem Cell 2012, 10:515-519.
69. Liu L., Rando T.A. Manifestations and mechanisms of stem cell aging. J Cell Biol 2011, 193:257-266.
70. Conboy I.M., Conboy M.J., Wagers A.J., Girma E.R., Weissman I.L., Rando T.A. Rejuvenation of aged progenitor cells by exposure to a young systemic environment. Nature 2005, 433:760-764.
71. Brack A.S., Conboy M.J., Roy S., Lee M., Kuo C.J., Keller C., Rando T.A. Increased Wnt signaling during aging alters muscle stem cell fate and increases fibrosis. Science 2007, 317:807-810.
72. Conboy I.M., Rando T.A. Heterochronic parabiosis for the study of the effects of aging on stem cells and their niches. Cell Cycle 2012, 11:2260-2267.
73. Scaffidi P., Misteli T. Lamin A-dependent misregulation of adult stem cells associated with accelerated ageing. Nat Cell Biol 2008, 10:452-459.
74. Espada J., Varela I., Flores I., Ugalde A.P., Cadinanos J., Pendas A.M., Stewart C.L., Tryggvason K., Blasco M.A., Freije J.M., et al. Nuclear envelope defects cause stem cell dysfunction in premature-aging mice. J Cell Biol 2008, 181:27-35.
75. Rosengardten Y., McKenna T., Grochova D., Eriksson M. Stem cell depletion in Hutchinson-Gilford progeria syndrome. Aging Cell 2011, 10:1011-1020.
76. Lavasani M., Robinson A.R., Lu A., Song M., Feduska J.M., Ahani B., Tilstra J.S., Feldman C.H., Robbins P.D., Niedernhofer L.J., et al. Muscle-derived stem/progenitor cell dysfunction limits healthspan and lifespan in a murine progeria model. Nat Commun 2012, 3:608.
77. Ahlqvist K.J., Hamalainen R.H., Yatsuga S., Uutela M., Terzioglu M., Gotz A., Forsstrom S., Salven P., Angers-Loustau A., Kopra O.H., et al. Somatic progenitor cell vulnerability to mitochondrial DNA mutagenesis underlies progeroid phenotypes in Polg mutator mice. Cell Metab 2012, 15:100-109.
78. Rando T.A., Chang H.Y. Aging, rejuvenation, and epigenetic reprogramming: resetting the aging clock. Cell 2012, 148:46-57.
79. Banito A., Rashid S.T., Acosta J.C., Li S., Pereira C.F., Geti I., Pinho S., Silva J.C., Azuara V., Walsh M., et al. Senescence impairs successful reprogramming to pluripotent stem cells. Genes Dev 2009, 23:2134-2139.
80. Lapasset L., Milhavet O., Prieur A., Besnard E., Babled A., Ait-Hamou N., Leschik J., Pellestor F., Ramirez J.M., De Vos J., et al. Rejuvenating senescent and centenarian human cells by reprogramming through the pluripotent state. Genes Dev 2011, 25:2248-2253.
81. Liu G.H., Barkho B.Z., Ruiz S., Diep D., Qu J., Yang S.L., Panopoulos A.D., Suzuki K., Kurian L., Walsh C., et al. Recapitulation of premature ageing with iPSCs from Hutchinson-Gilford progeria syndrome. Nature 2011, 472:221-225.
82. Zhang J., Lian Q., Zhu G., Zhou F., Sui L., Tan C., Mutalif R.A., Navasankari R., Zhang Y., Tse H.F., et al. A human iPSC model of Hutchinson Gilford Progeria reveals vascular smooth muscle and mesenchymal stem cell defects. Cell Stem Cell 2011, 8:31-45.
83. Ho J.C., Zhou T., Lai W.H., Huang Y., Chan Y.C., Li X., Wong N.L., Li Y., Au K.W., Guo D., et al. Generation of induced pluripotent stem cell lines from 3 distinct laminopathies bearing heterogeneous mutations in lamin A/C. Aging (Albany NY) 2011, 3:380-390.
84. Constantinescu D., Gray H.L., Sammak P.J., Schatten G.P., Csoka A.B. Lamin A/C expression is a marker of mouse and human embryonic stem cell differentiation. Stem Cells 2006, 24:177-185.
85. Liu G.H., Suzuki K., Qu J., Sancho-Martinez I., Yi F., Li M., Kumar S., Nivet E., Kim J., Soligalla R.D., et al. Targeted gene correction of laminopathy-associated LMNA mutations in patient-specific iPSCs. Cell Stem Cell 2011, 8:688-694.
86. Jaskelioff M., Muller F.L., Paik J.H., Thomas E., Jiang S., Adams A.C., Sahin E., Kost-Alimova M., Protopopov A., Cadinanos J., et al. Telomerase reactivation reverses tissue degeneration in aged telomerase-deficient mice. Nature 2011, 469:102-106.
87. de Jesus B.B., Schneeberger K., Vera E., Tejera A., Harley C.B., Blasco M.A. The telomerase activator TA-65 elongates short telomeres and increases health span of adult/old mice without increasing cancer incidence. Aging Cell 2011, 10:604-621.
88. Bernardes de Jesus B., Vera E., Schneeberger K., Tejera A.M., Ayuso E., Bosch F., Blasco M.A. Telomerase gene therapy in adult and old mice delays aging and increases longevity without increasing cancer. EMBO Mol Med 2012, [Epub ahead of print]. 10.1002/emmm.201200245.